The Food and Drug Administration offers a funding opportunity focused on novel approaches to support therapeutic development in ultra-rare cancers. Specific details on eligibility, application requirements, and funding amount are not provided. The deadline for applications is May 19, 2026.
Eligibility details not specified in the grant listing. Contact the funding organization for requirements.
